A novel effect of nicotine on mood and sleep in major depression

NeuroReport

Volumn 9, Issue 1, 1998, Pages 57-60

  Salín Pascual, Rafael J ^a,b,c   Drucker Colín, René ^a,b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c HOSPITAL PSIQUIÁTRICO FRAY BERNARDINO ÁLVAREZ   (Mexico)

Author keywords

Major depression; Nicotine; REM sleep

Indexed keywords

NICOTINE;

ACCLIMATIZATION; ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; HAMILTON SCALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REM SLEEP; SLEEP PATTERN; SMOKING; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032484644     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199801050-00012     Document Type: Article

References (22)

1. Gillin JC and Shiromani P. Cholinergic mechanisms in sleep. In: Montplaisir J and Godbout R, eds. Sleep and Biological Rhythms. Oxford: Oxford University Press, 1990: 186-208.
2. Vogel GW. Arch Gen Psychiatry 32, 749-761 (1975).
3. Gillin JC, Salín-Pascual RJ, Velázquez-Moctezuma J et al. Prog Brain Res 90, 379-387 (1993).
4. Montgomery SA. Selective serotonin reuptake inhibitors in the acute treatment of depression. In: Bloom E and Kupfer DJ, eds. Psychopharmacology. The Fourth Generation of Progress. New York: Raven Press, 1995: 1043-1051.
5. Vázquez J, Guzmán-Marín R, Salín-Pascual RJ and Drucker Colin R. Brain Res 737, 317-320 (1996).
6. Simmon RP, Gershon MD and Brooks DC. Brain Res 50, 313-330 (1973).
7. Delashow JB, Foutz AS, Guílleminault C and Dement WC. Exp Neurol 66, 745-757 (1979).
8. Domino EF and Yamamoto K. Science 150, 637-638 (1966).
9. Jewet RE and Norton S. Exp Neurol 15, 463-474 (1966).
10. Velázquez-Moctezuma J, Shalauta MD, Gillin JC and Shiromani P. Neurosci Lett 115, 265-268 (1990).
11. Gillin JC, Lardon M, Ruiz C et al. J Clin Psychopharmacol 14, 264-267 (1994).
12. Salín-Pascual RJ, De la Fuente JR, Galicia-Polo L and Drucker Colín R. Psychopharmacology 121, 476-479 (1995).
13. Glassman A, Helzer JE, Covey LS et al. J Am Med Assoc 264, 1546-1549 (1990).
14. Covey LS, Glassman AH and Stetner F. Am J Psychiatry 154, 263-265 (1997).
15. Spitzer RL, Williams JBW and Gibbon M. Structured Clinical Interview for DSM-III-R (SCID). New York: New York Biometric Research, 1987.
16. Rechtschaffen A and Kales AA. A Manual of Standardized Terminology. Techniques and Scoring System for Sleep Stages of Human Subjects. Washington: Public Health Service, 1968.
17. Taylor P. Ganglionic stimulating and blocking agents. In: Goodman Gilman A. Goodman LS and Gilman A, eds. The Pharmacological Basis of Therapeutics, 6th edn. New York: McMillan 1995: 214.
18. Datta S, Calvo JM, Quattrochi JJ and Hobson JA. NeuroReport 2, 619-622 (1991).
19. Dilsaver C. Brain Res Rev 11, 285-316 (1986).
20. Sitaram N and Gillin JC. Biol Psychiatry 15, 925-955 (1980).
21. Fritch Montero R, Riedmann D and Berger D. Antidepressant and antimanic drugs. In: Kales A, ed. The Pharmacology of Sleep. New York: Springer-Verlag, 1995: 465-490.
22. Iwamoto ET. J Pharmacol Exp Ther 251, 412-421 (1988).